Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris
Clinical trial NCT05131373 · COMPLETED
Trial details
- NCT number
- NCT05131373
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2023-11-27
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.